Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00193245 | Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193323 | Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients | completed | Phase 2 | 346 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193349 | Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | Jun 28, 2010 | clinicaltrials |
| NCT00294931 | Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00308529 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00003154 | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00006017 | Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00053300 | Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | completed | Phase 2 | 47 | Genentech, Inc.INDUSTRY | 0 | May 11, 2010 | clinicaltrials |
| NCT00198393 | Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV | completed | Phase 2 | 126 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 57 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 165 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00456716 | Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma | completed | Phase 2 | 5 | Swedish Medical CenterOTHER | 1 | Mar 4, 2010 | clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00174772 | Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 72 | SanofiINDUSTRY | 8 | Feb 17, 2010 | clinicaltrials |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 17, 2010 | clinicaltrials |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 133 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 17, 2010 | clinicaltrials |
| NCT00039507 | Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | — | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00128999 | Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 5 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00114192 | Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | University of VirginiaOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT01048645 | Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT01037998 | UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer | completed | Phase 2 | 115 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00615758 | Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00684099 | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 70 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 226 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00258739 | Docetaxel in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00271271 | Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients(GON) | completed | Phase 2 | 40 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00424853 | ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 88 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00425191 | Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. | completed | Phase 2 | 165 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 19 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 20, 2009 | clinicaltrials |
| NCT00212043 | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma | completed | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 0 | Oct 8, 2009 | clinicaltrials |
| NCT00990535 | High Dose Somatostatin Analogues in Neuroendocrine Tumors(HIDONET) | completed | Phase 2 | 28 | Federico II UniversityOTHER | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00319969 | Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. | completed | Phase 2 | 76 | Celgene CorporationINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00004924 | Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 28 | Yale UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00063219 | Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy | completed | Phase 2 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00067548 | Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00264498 | Phase II Iressa & Carbo/Gem in NSCLC | completed | Phase 2 | 38 | AstraZenecaINDUSTRY | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00295672 | Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.(VINCR) | completed | Phase 2 | 60 | University Hospital, BrestOTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00744900 | Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)(GFPC 07-01) | completed | Phase 2 | 45 | University Hospital, BrestOTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00165334 | Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer | completed | Phase 2 | 53 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 22, 2009 | clinicaltrials |
| NCT00181506 | HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy | completed | Phase 1 / Phase 2 | 180 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00181532 | Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC | completed | Phase 2 | 102 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00044538 | Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 102 | BayerINDUSTRY | 6 | Jun 22, 2009 | clinicaltrials |
| NCT00034164 | Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer | completed | Phase 2 | 52 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00167401 | Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of RochesterOTHER | 1 | May 19, 2009 | clinicaltrials |
| NCT00036023 | Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies | completed | Phase 2 | — | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jun 28, 2010source: clinicaltrials